The epidermal growth factor receptor (EGFR) has evolved over years into a main molecular
target for the treatment of different cancer entities. In this regard, the anti-EGFR antibody …

Purpose Radiotherapy plus cetuximab is an effective combination therapy for locally
advanced head and neck squamous cell carcinoma. The aim of our study was to determine …

Concurrent chemoradiotherapy with high-dose cisplatin (100 mg/m2 every 3 weeks) is the
preferred regimen with curative intent for patients with unresected locally advanced …

The epidermal growth factor receptor (EGFR) is one of the most comprehensively studied
molecular targets in head and neck squamous cell carcinoma (HNSCC). However, inherent …

Objective This study aimed to investigate the efficacy of induction chemotherapy followed by
concurrent chemotherapy and helical tomotherapy in patients with T4b squamous cell …

Radiotherapy is one of the most common form of treatment in oncology care. Indeed,
radiotherapy proved to be very effective in treating a wide range of malignancies …

The document is based on consensus among the experts and best available evidence
pertaining to Indian population and is meant for practice in India.• Evaluation of a patient …

In this article, we highlight the evolution of a multimodal approach in the overall
management of squamous cell carcinoma of the head and neck (SCCHN) in India; present …

Background: The majority of lip cancer is the squamous cell carcinoma (SCC) type that
exhibits clinical and biological characteristics intermediate between skin and oral SCC. The …

We review clinical trials of squamous cell carcinoma of the head and neck (SCCHN) to
address the current and potential uses of cetuximab (CTX). PubMed was reviewed to identify …